Latest filing published 12 Mar 2018 for IMMUNOMEDICS INC, €282k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David M. Goldenberg: trading record in brief
David M. Goldenberg is a declared insider of Immunomedics Inc, with filings sourced from SEC (Form 4). In total, 201 filings cover trades dated from 4 April 2006 to 7 March 2018.
The open-market side counts 7 purchases for €230k alongside 35 sales for €6.9M. Taken together, the sales exceed the purchases by €6.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 30 share grants and 23 option exercises. 2018 to date brings no purchases and 6 sales.
Half of the purchases are above €5,465 and half below.
The newest entry dates from 12 March 2018: an open-market sale of €282k, in Immunomedics Inc. The clock since the last published purchase (6 March 2009) now reads 6,456 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David M. Goldenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$17.504.4% of flowCommon StockSEC:0001104659-18-016854:0
- 17,729 shares@ US$17.093.9% of flowCommon StockSEC:0001104659-18-016854:1
- 20,000 shares@ US$17.304.4% of flowCommon StockSEC:0001104659-18-016854:2
- 20,000 shares@ US$17.174.4% of flowCommon StockSEC:0001104659-18-016854:3
- 20,000 shares@ US$17.604.4% of flowCommon StockSEC:0001104659-18-016854:4
- 20,000 shares@ US$17.754.5% of flowCommon StockSEC:0001104659-18-016854:5
- 5,000 shares@ US$12.250.8% of flowCommon StockSEC:0001171843-17-005395:0
- 5,000 shares@ US$12.500.8% of flowCommon StockSEC:0001171843-17-005395:1
- 10,000 shares@ US$12.901.7% of flowCommon StockSEC:0001171843-17-005395:2
- 25,000 shares@ US$10.243.4% of flowCommon StockSEC:0001171843-17-005277:0
- 5,000 shares@ US$11.450.7% of flowCommon StockSEC:0001171843-17-005277:1
- 10,000 shares@ US$11.561.5% of flowCommon StockSEC:0001171843-17-005277:2
- 10,000 shares@ US$9.501.3% of flowCommon StockSEC:0001171843-17-005225:2
- 20,000 shares@ US$8.972.4% of flowCommon StockSEC:0001171843-17-005225:0
- 10,000 shares@ US$9.501.3% of flowCommon StockSEC:0001171843-17-005225:1
- 4,874 shares0Common StockSEC:0001171843-17-004625:0
- 1,950 shares@ US$8.750.2% of flowCommon StockSEC:0001171843-17-004625:1
- 4,873 shares0Common StockSEC:0001171843-17-004625:2
- 106,061 shares0Common StockSEC:0001171843-16-012251:0
- 4,873 shares0Common StockSEC:0001171843-16-011400:0
- 4,873 shares0Common StockSEC:0001171843-16-011400:2
- 1,950 shares@ US$2.610.1% of flowCommon StockSEC:0001171843-16-011400:1
- 81,990 shares@ US$2.502.8% of flowCommon StockSEC:0001171843-16-010659:0
- 10,050 shares@ US$2.630.4% of flowCommon StockSEC:0001171843-16-010659:1
- 92,040 shares@ US$3.053.9% of flowCommon StockSEC:0001171843-16-010659:2
25 of 191 declarations
